Thermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $2.03, $0.02 better than the analyst estimate of $2.01. Revenue for the quarter came in at $4.54 billion versus the consensus estimate of $4.5 billion.

GUIDANCE:

Thermo Fisher Scientific sees FY2016 EPS of $8.07-$8.20, versus prior guidance of $8.05-$8.19 and the consensus of $8.13. Thermo Fisher Scientific sees FY2016 revenue of $17.84-18.0 billion, versus prior guidance of $17.86-18.04 billion and the consensus of $17.94 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.